INTRODUCTION
It has recently been shown that the lipid mediator platelet-activating factor (PAF, paf-acether, 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) can cause gastric ulcerations when infused intravenously into experimental animals [1] . Hitherto, some studies have been carried out showing the inhibition by PAF antagonists of different types of gastric ulcerations [2] , but data are lacking as to the potential of the gastric mucosa to generate the mediator. This pathophysiological approach to understanding the role of PAF in gastric mucosa is encouraged by the recent finding that short-term stimulation of PAF synthesis occurs during the stimulation of exocrine glands, i.e. isolated acini from guinea pig parotid gland and pancreas [3] [4] [5] , and which suggests a widespread role for this highly active biological lipid in tissues containing exocrine secretory glands such as the gastric mucosa.
Biosynthesis of PAF may occur through two pathways. One has as a limiting step the acetylation of lyso-PAF [6] and the other includes among its final steps the acetylation of l-0-alkyl-2-lyso-sn-glycero-3-phosphate (alkyl-lyso-GP) [7] and the transfer of phosphocholine to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphate (alkylacetyl-GP) via a 'de novo' pathway involving a dithiothreitol (DTT)-insensitive cholinephosphotransferase [8] . In this study we report: (1) the presence of enzymes of the 'de novo' pathway and the absence of 1-0-alkyl-2-lysosn-glycero-3-phosphocholine (lyso-PAF): acetyl-CoA acetyltransferase (EC 2.3.1.67) in the glandular mucosa; (2) the presence of significant amounts of PAF in the glandular mucosa; (3) the possible modulation of DTTinsensitive cholinephosphotransferase by low concentrations of fatty acids; (4) the presence of small amounts of other enzymes acting on PAF metabolism.
MATERIALS AND METHODS

Reagents
1-0-Hexadecyl-2-acetyl-sn-glycerol was from Novabiochem AG, Laufelfingen, Switzerland. 1-0-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (synthetic PAF) and 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine Vol. 254 Abbreviations used: alkylacetyl-G, 1-O-alkyl-2-acetyl-sn-glycerol; alkyl-lyso-G, 1-O-alkyl-2-lyso-sn-glycerol; alkylacetyl-GP, 1-O-alkyl-2-acetylsn-glycero-3-phosphate; alkyl-lyso-GP, 1-O-alkyl-2-lyso-sn-glycero-3-phosphate; PAF, platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine); lyso-PAF, 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine; DTT, dithiothreitol.
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(synthetic lyso-PAF) were from Bachem Feinchemikalien, Bubendorf, Switzerland. Phospholipase D from Streptomyces chromofuscus and acetyl-CoA were from Boehringer Mannheim GmbH, F.R.G. Analytical silica gel plates were from Merck, Darmstadt, F.R.G.
[3H]Acetyl-CoA (2 Ci/mmol), CDP-[methyl-'4C]choline (58 Ci/mmol), [3H]alkylacetyl-glycero-3-phosphocholine (80 Ci/mmol) and [3H]alkyl-lyso-glycero-3-phosphocholine (120 Ci/mmol) were from The Radiochemical Centre, Amersham, U.K. Oleic acid, 1,2-dioleoylsn-glycerol, dipalmitoyl-sn-3-glycero-3-phosphocholine, l-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, palmitic acid, indomethacin and nordihydroguaiaretic acid were from Sigma Chemical Co., St. Louis, MO, U.S.A. Arachidonic acid was from Behring Diagnostics, La Jolla, CA, U.S.A. Alkyl-lyso-glycero-3-phosphate was prepared by treating PAF with phospholipase D according to the procedure described by Lee et al. [7] . The resulting alkylacetyl-glycero-3-phosphate was subsequently saponified [9] to remove the acetyl group at the sn-2 position of the glycerol. Both products were extracted from the reaction mixtures by a modified method of Bligh & Dyer [10] , except 2 % acetic acid was included in the methanol and 0.1 M-HCI was used as the aqueous phase. Purification of alkyl-lyso-glycero-3-phosphate was achieved by preparative t.l.c. on silica gel plates developed in chloroform/methanol/conc. NH40H (65:35:8, by vol.) (system I). To control the efficiency of this procedure for preparing the substrate, some experiments were carried out in parallel using [3H]PAF as a tracer. This allowed us to calculate the yield of the procedure as about 30 % of the initial amount of PAF. The amount of alkyl-lyso-glycero-3-phosphate was quantified by measuring phospholipid-associated P by the procedure of Rouser et al. [11] . Isolation of glandular gastric mucosa
Wistar rats of about 200 g were routinely used throughout the study. They were exsanguinated by heart puncture followed by perfusion with cold saline solution, and the stomachs removed, cut open along the greater curvature and flushed with cold saline solution. The mucosa was peeled off and the glandular portion separated from the fundal portion, i.e. the non-secreting part covered with a squamous epithelium, and transferred into a glass Potter tube for mechanical disruption with a motor-driven Teflon pestle. After disruption, the homogenate was mesh filtered to remove crude material and centrifuged at 900 g at 4°C for 10 min. The supernatant was then sequentially centrifuged at 10000 g, at 27800 g and finally at 105000 g for 1 h at 4 'C. The pellet was resuspended in the medium used for enzyme activity measurements. The medium used for the isolation of the microsomal fraction was 0.1 M-Tris/HCl, pH 7.4, containing 0.3 M-sucrose, 0.5 mg of soybean trypsin inhibitor/ml and 50 ,ug of leupeptin/ml if lyso-PAF: acetyl-CoA acetyltransferase or DTT-insensitive cholinephosphotransferase was to be assayed. If the purpose of the experiment was to measure alkyl-lyso-GP: acetyl-CoA acetyltransferase, the isolation medium contained 0.25 M-sucrose, 20 mM-Tris/HCl, 10 mm-EDTA, 5 mM-mercaptoethanol, 50 mM-NaF and 25 ,sMsodium vanadate, pH 7.4 . The amount of protein contained in microsomal fractions was assayed by the procedure of Bradford [12] . Rat spleens were processed in parallel for assay of the same enzyme activities.
Assay of lyso-PAF: acetyl-CoA acetyltransferase (EC 2.3.1.67)
The acetylation reaction [6, 13] CDP-[methyl-'4C]choline and 100 M unlabelled CDPcholine. The reaction was allowed to proceed for 10 min and the procedures of lipid extraction and t.l.c. were analogous to those described above.
Diacylglycerol: CDP-choline cholinephosphotransferase (EC 2.7.8.2) was assayed in the absence of DTT and using 50 /uM-1,2-diolein, instead of 1-O-hexadecyl-2-acetyl-sn-glycerol as substrate. Samples were processed under the same conditions, except that the area migrating as a standard of phosphatidylcholine was scraped off and transferred to containers for liquid-scintillation spectrometry.
Assay of alkyl-lyso-GP: acetyl-CoA acetyltransferase
The assay was performed in a 0.1 M-Tris/HCl buffer, pH 8.4, containing 50 mM-NaF, 25 ,uM-sodium vanadate, 16 /sM-alkyl-lyso-GP, 3 ,uCi of [3H]acetyl-CoA and 600 #M unlabelled acetyl-CoA. The incubation was carried out at 23 IC for up to 5 min [7] . Reactions were stopped by addition of 0.5 ml of 20 % trichloroacetic acid followed by centrifugation and lipid extraction as specified above, except that 100 ,g of phosphatidylcholine was added as a lipid carrier. Products formed in the incubations were analysed by t.l.c. using as developer system I. In this system the RF of alkylacetyl-GP is 0.1 1, whereas alkylacetyl-G migrates near the solvent front (RF = 0.94). Further characterization of the product was performed using as developer chloroform/methanol/ acetic acid (96:4: 1, by vol.) (system III). In this system alkylacetyl-G migrates with an RF of 0.43. Distribution of the label by areas was determined by zonal scraping and liquid-scintillation spectrometry. Assay of lysophospholipase D activity Since marked differences in the properties of lysophospholipase D have been reported, this enzyme activity was assayed under the conditions described by Wykle & Schremmer [14] in rat tissues as well as under those of Kawasaki & Snyder [15] , supplemented with 5 mM-CaCl2. All incubations were carried out in a vol. of 1 ml of 37°C for 10 min, and the reaction was terminated by extracting the lipids using the procedure of Bligh & Dyer [10] , with the modification of the presence of 2 % glacial acetic acid in the methanol and the addition of 100 ,tg of phosphatidylcholine as carrier phospholipid for t.l.c. The alkyl-lyso-G and alkyl-lyso-GP formed were assayed after separation by t.l.c. using system I as well as the developer hexane/ diethyl ether/methanol (85:20:5, by vol.) (system IV).
Phospholipase A2 activity assay Phospholipase A2 was determined as described by Hirohara et al. [16] for the gastric enzyme activity. The assay solution consisted of 100 /mM-1-palmitoyl-2-oleoylsn-glycero-3-phosphocholine, 0.2,uCi of 1-palmitoyl-2-[1-'4C]oleoyl-sn-glycero-3-phosphocholine and 2 mMCaCl2 in a Tris/HCl buffer, pH 8, in a volume of 1 ml.
The reaction was incubated at 37°C for 10 min and was stopped by Bligh & Dyer extraction [10] . The reaction products in the chloroform layer were separated by t.l.c.
in the system of solvents propionic acid/propanol/ chloroform/water (50:25:8:6, by vol.) (system V) and the radioactivity associated with both neutral lipid and phosphatidylcholine fractions was assayed by liquidscintillation spectrometry.
PAF acetylhydrolase (EC 3.1.1.47)
The reaction was carried out in a 0.1 mM-Tris/HCl buffer, pH 8, containing 100 #,M-PAF and 0.2,Ci of
[3H]PAF, in a volume of 1 ml [17] . The reaction was carried out and terminated as described for phospholipase A2 assay, except that the radioactivity associated with the areas migrating as both PAF and lyso-PAF was quantified.
Extraction, characterization and assay of PAF PAF was extracted from homogenates of gastric mucosa by the procedure of Bligh & Dyer [10] . The aqueous layer was washed twice with chloroform and all the chloroform extracts pooled and evaporated to dryness under N2 stream. PAF was bioassayed on [3H]serotoninlabelled rabbit platelets and characterized as described in ref. [18] , as well as by both straight-and reverse-phase h.p.l.c. Straight-phase h.p.l.c. was carried out using a dual-pump Kontron Model 420 system, fitted with a Spheri-5 Silica (220 mm x 4.6 mm, 5 ,um) column from Brownlee Laboratories, Santa Clara, CA, U.S.A. The solvent system used was: 96 % propan-2-ol: hexane (1: 1), containing 0.005 % glacial acetic acid/4 % water; the percentage ofwater was increased linearly to 8 % over a 1 5-min period [19] . The chromatography proceeded for 60 min at 1 ml/min, and 1 ml fractions were collected, evaporated to dryness and used for bioassay. Isocratic reverse-phase h.p.l.c. was carried out using a Spheri-5 RP 18 (220 mm x 4.6 mm, 5 /im) column. The mobile phase was methanol/water/acetonitrile (17:2:1, by vol.) containing 20 mM-choline chloride [20] . PAF was quantified using a standard curve constructed with synthetic PAF (hexadecyl) and expressed as ng equivalents.
Vol. 254 RESULTS Lyso-PAF: acetyl-CoA acetyltransferase activity Gastric microsomes incubated under the conditions of the assay incorporated the label into a lipid compound with an RF of 0.78 in system II, whereas no incorporation of label was seen in the area migrating as PAF (RF = 0.32). This incorporation oflabel was also observed in the absence of lyso-PAF, but was not found when microsomes were boiled for 2 min prior to the enzyme assay. When the lipid extract was chromatographed in system III, the label was found in the area migrating with an RF analogous to that of alkylacetyl-G, i.e. 0.43. These findings suggest that either lyso-PAF: acetyl-CoA acetyltransferase is absent from glandular stomach preparations or it is strongly inhibited by an as yet unknown substance. To test the hypothesis of a possible inhibitor, the effect of gastric microsomes on lyso-PAF: acetyl-CoA acetyltransferase activity of rat spleens, a known source of this enzyme activity, was tested. Addition of gastric mucosa microsomes to spleen microsomes at different ratios (up to 3 mg of protein from gastric mucosa microsomes per mg of protein from spleen microsomes) did not modify lyso-PAF: acetylCoA acetyltransferase, and this was seen as an argument against the existence of an inhibitor. However, a caution should be mentioned before ruling out a possible inhibitor, since the effect of a lipophilic compound needing inter-membrane transfer has not been fully discarded.
Alkyl-lyso-GP: acetyl-CoA acetyltransferase activity This enzyme activity was assayed in spleen and gastric microsomes. Gastric microsomes contained about onetenth of the activity assayed in the spleen. Interestingly, in the absence of NaF and sodium vanadate all the label migrated as alkylacetyl-G, whereas in the presence of both inhibitors of phosphohydrolase about a half of the label migrated as alkylacetyl-GP. This is strong evidence for the existence of the enzyme which cleaves the phosphate moiety from alkyl-lyso-GP and provides the substrate for the cholinephosphotransferase. Alkyllyso-GP: acetyl-CoA acetyltransferase activity was also detected in the absence of exogenous alkyl-lyso-GP which suggests that endogenous substrate was present. Kinetic analysis of the enzyme activity showed an apparent Km for acetyl-CoA of 454 /zM, a value slightly higher than that found in spleen microsomes (277 /zM), which is in keeping with the value of 226 /M reported by Lee et al. in spleen microsomes [7] . The V... was 0.1 nmol/min mg of protein for the gastric enzyme and 1 nmol/min mg of protein for the splenic enzyme (Fig. 1) .
Alkylacetyl-G:CDP-choline cholinephosphotransferase activity
The mean Vmax for this enzyme from gastric microsomes was 3.12 + 0.05 nmol/min -mg of protein when the assay medium contained 50,1M-alkylacetyl-G (n = 5) (Fig. 2) . In the absence of this co-substrate, negligible incorporation of the label into PAF was observed. The apparent Km value for CDP-choline was 67 sM. In parallel experiments using spleen microsomes from the same animals, the specific activity of DTTinsensitive cholinephosphotransferase was modulation of this enzyme activity, microsomes were incubated with different concentrations of fatty acids (arachidonic, oleic and palmitic), 1,2-diolein or phosphatidylcholine for 10 min prior to the addition of the substrates. Arachidonic and oleic acids inhibited the formation of [3H]PAF in a dose-dependent manner (results not shown), whereas palmitic acid was less active. Half-maximal effective doses are given in Table 1 . The effect of arachidonic acid on the formation of PAF with time was studied at two different concentrations of arachidonic acid and is shown in Fig. 3 . To determine whether the action of arachidonic acid could be traced to its metabolic transformation into another product, experiments were performed which included a period of incubation with indomethacin, an inhibitor of cyclooxygenase, and with nordihydroguaiaretic acid, a known inhibitor of both cyclo-oxygenase and lipoxygenase, prior to the addition of arachidonate. Under these conditions, the effect of arachidonic acid was still observed, with a percentage of variation of less than 5 0 in three independent experiments. Phosphatidylcholine (dipalmitoyl) caused a small increase in DTT-insensitive cholinephosphotransferase activity at 1O /tM and a 160% reduction at 100l M ( out in the presence of 0.13 M-KCl, a concentration of salt which reduces the concentration of lipids required for the formation of micelles, and which reduced enzyme activity by 35 0, although fatty acids still showed the same degree of inhibitory action (results not shown). These findings, together with the action of oleic acid and the reduced effect of palmitic acid, surely indicate an inhibitory effect by fatty acids by themselves rather than an action linked to metabolic conversion. Double- found was not restricted to the enzyme activity involved in PAF formation (Table 3) . Lysophospholipase D, phospholipase A2 and PAF acetylhydrolase activities Initial findings of the lack of lyso-PAF: acetyl-CoA acetyltransferase activity prompted a detailed analysis of the mechanism for interference with the assay by competition with either substrates or reaction products, and the above mentioned enzyme activities were assayed. Lysophospholipase D activity with specificity for ether lipids was measured in gastric microsomes (Table 4) . This activity was not observed when 1 -palmitoyl-2-lysosn-glycero-3-phosphocholine was used as substrate (results not shown) and required Mg2" ions for optimal expression. These findings, together with the lack of effect of Ca2+ ions and the interval for optimal pH (no activity could be assayed at pH 8.4), indicate that the lysophospholipase D activity assayed in gastric microsomes is analogous to the enzyme reported by Wykle & Schremmer [14] in rat tissues, rather than to the enzyme reported by Kawasaki & Snyder [15] in rabbit PAF degradation in the gastric mucosa is carried out by PAF-acetylhydrolase rather than by phospholipase A2.
Presence of PAF in glandular gastric mucosa homogenates PAF extracted from 10 different specimens of glandular-gastric-mucosa homogenates was assayed and found at a coincentration of 2.7 + 0.7 ng equivalents of PAF (hexadecyl)/mg of protein. Analysis of gastric PAF by straight-phase h.p.l.c. showed a retention time of 34 min (Fig. 4a) . Reverse-phase h.p.l.c., in a system usually used to unmask differences in molecular species of alkyl chains, showed that most of the PAF extracted from gastric mucosa showed a retention time analogous to that of a [3H]hexadecyl standard (Fig. 4b) 
